SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Galderma Laboratories Receives FDA Approval for New Convenient Pump Dispenser of Differin(R) Gel, 0.3% for Treatment of Acne Vulgaris